Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective

Similar documents
Supplemental Table 1.1: Prostate cancer prognostic tools

SCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017

JOINT STATEMENT BY MEMBERS OF THE NATIONAL COMPREHENSIVE CANCER NETWORK PROSTATE CANCER GUIDELINES PANEL

Ludwig Presence at 2016 ASCO Annual Meeting

Chapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation

ESMO Symposium on Immuno-Oncology Programme book

St. Michael s Hospital, Department of Medical Imaging invites you to join us for a live conference and live webinar: 4 th Annual MRI Symposium

ALBERTA PRINCIPAL INVESTIGATORS

Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd

FERTIPROTECT rd Annual Conference

Gastric Cancer Co-Chairs Speakers LEARNING OBJECTIVES

Oncofertility: The Preservation of Fertility Options for Young People with Cancer

Background Management of high risk, early stage endometrial cancer is controversial. Historically, adjuvant pelvic radiation therapy is standard for

Multigene Panel Testing for Hereditary Cancer Risk

Steamboat Springs, Colorado. January 15-18, 2016

ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain

Hall 406. Title: Opening & Keynote. Hall 405. Title: Treatment of node positive bladder. Hall 404

ENYGO REPORT. Summary

PRELIMINARY PROGRAM MAY 31 - JUNE 4, 2019

Ovarian Cancers: Evolving Paradigms in Research and Care Report Release Wednesday, March 2, 2016

第 1 章医学英語. 1. 病院 Hospital 人体 Human Body 20. Preface. English of Medical Terms

CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018

Clinical utility of precision medicine in oncology

Qualification Statement: As Assistant Professor and Director of Clinical & Community Relations, Professor Longpré is part of the founding faculty for

2008 Oncology Pharmacy Preparatory Review Course Learning Objectives

DEPARTMENT OF ONCOLOGY ELECTIVE

Precision Genetic Testing in Cancer Treatment and Prognosis

International Symposium on FERTILITY PRESERVATION Basic Research to Clinical Applications

Unknown Primary Service for patients at Chesterfield Royal Hospital

AGENDA: FEBRUARY 22, 2018 INTRODUCTION

Charisse Litchman Editor. Desmoid Tumors

SLN Mapping in Cervical Cancer. Memorial Sloan Kettering Cancer Center New York, USA

Adaptive Design of Affordable Clinical Trials Using Master Protocols in the Era of Precision Medicine

Macmillan Publications

Future Therapeutic Developments in Head and Neck Cancer

Discussing Fertility Preservation with Breast Cancer Patients

第 108 回日本精神神経学会学術総会 教育講演 REM REM 索引用語 はじめに. sleep psychiatry 26

SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER

MEDICAL ONCOLOGY ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN. 27 June - 2 July 2014 Brdo, Slovenia. Chairs: T. Cufer, SI R.

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer. American Society of Clinical Oncology Clinical Practice Guideline

Dr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah

ECC or Margins Positive?

Auditorium. Title: Welcome and Introduction by the Chairs Moderation: M. Pless, A. Cervantes ; Winterthur, CH, Valencia, ES

BGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford

Oncology 101. Cancer Basics

THE UC SANTA CRUZ GENOMICS INSTITUTE. David Haussler Distinguished Professor, Biomolecular Engineering Scientific Director

Scientific Program, 2 nd ISFP World Congress

56 th Annual Meeting American Society for Radiation Oncology. Advances in Lung Caner News Briefing

Ontario s Initiatives in Surgical Quality- The Successes & Where We are Going

Dr Graeme Suthers: The genetic basis of cancer

American Cancer Society, Inc. Extramural Grants

CYPRESS U CRITICAL UPDATE

DONNA BOWERS & ALAN MILLER

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

ESO-ASCO MASTERCLASS IN CLINICAL ONCOLOGY November 2018 Yerevan, Armenia MASTERCLASS

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves Douillard, France

American Cancer Society, Inc. Extramural Grants

Year Book 7 副腎 国立成育医療研究センター研究所 分子内分泌研究部 勝又規行 第 51 回日本内分泌学会学術総会

COSA Invited International Speakers

NATIONAL CORPORATE MEDICAL ASSOCIATES: CANCER TREATMENT UPDATE 2016

Preliminary programme ESLCCC September 2016

Cancer immunotherapy with oncolytic viruses: more than just lysis

Page 1 of 8 TABLE OF CONTENTS

DCIS: Margins and the USC/VNPI

55 th Annual Meeting American Society for Radiation Oncology. Patients: Hope Guide Heal News Briefing

Presented at the 59th American Society of Hematology (ASH) Annual Meeting & Exposition; December 9 12, 2017; Atlanta, GA, USA

Trends in Cancer Survival in NSW 1980 to 1996

Professional International Study Management

M. Patrick Lowe, M.D. Curriculum Vitae

Stage IB1 (2-4 cm) Cervical cancer treated with Neoadjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA) Dre Marie Plante

Annals of Oncology Advance Access published July 10, 2014

BGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford

News from ASCO. Niven Mehra, Medical Oncologist. Radboud UMC Institute of Cancer Research and The Royal Marsden Hospital

How can we reduce the mortality from melanoma in Australia?

BRCA2 gene. Associated Syndrome Name: Hereditary Breast and Ovarian Cancer syndrome (HBOC) BRCA2 Summary Cancer Risk Table. BRCA2 gene Overview

Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa

2010 Oncology Pharmacy Preparatory Review Course for Home Study Learning Objectives

UCL CANCER INSTITUTE. The UCLH / UCL Cancer Clinical Research Facility

MEDICAL POLICY. SUBJECT: MOLECULAR PANEL TESTING OF CANCERS TO IDENTIFY TARGETED THERAPIES (Excluding NSCLC and CRC) EFFECTIVE DATE: 12/21/17

References 1. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, CA Cancer J Clin, (1): p Keegan, T.H., et al., Compa

ORGANISING COMMITTEE

Acupuncture Needles. Overview. Gary Deng, MD,PhD. Traditional Theories. Acupuncture in Cancer Care: the USA Experience. History. Research Activities

8:30-9:00 Increased dependence on glutamine in PTEN-deficient breast cancer Ramon E. Parsons, Icahn School of Medicine at Mount Sinai, New York, NY

Pediatric Otolaryngology Fellowship News & Events

Cancer Researchers Report Longer Survival Rates With Immunotherapy

6 th MD ANDERSON INTERNATIONAL MEETING IN EMBRACING NEW STANDARDS OF CARE IN GYNECOLOGIC CANCERS PRELIMINARY PROGRAM. Meeting Directors:

2015 EUROPEAN CANCER CONGRESS

Roche Investor Relations ASCO Planner 2017

Lynch Syndrome: A Public Health Approach

Cancer Prevention & Control in Adolescent & Young Adult Survivors

Palliative care - the opportunities. Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital

FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center

Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain

Chapter 8 Adenocarcinoma

OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February

Introduction to Oncology and Chemotherapy October 23-24, 2013 San Francisco, CA

9th Annual Global Implantology Week At NYU

Transcription:

第 53 回日本癌治療学会学術集会 ASCO, ESMO, ECCO からの招聘演者と講演予定 Peter P. Yu (President of American Society of Clinical Oncology, ASCO) Collaboration between ASCO and JSCO: Future Perspective Ralf A. Stahel (President of European Society of Medical Oncology, ESMO) Globalization of Precision Medicine in Oncology Mark J. Ratain (Personalized Therapeutics, University of Chicago, USA) Germline Genetic Analysis and Cancer Pharmacogenomics Jedd D. Wolchok (Memorial Sloan Kettering Cancer Center, USA) Cancer Immunotherapy with Combination Checkpoint Blockade

Jelle Barentsz (Radiology Researchers, UMC St Radboud, Netherlands) Molecular and Functional Imaging of Lymph Node Metastasis Stephen J. Chanock (NCI Cancer Genomics Research Laboratory, USA) Germline Genetic Analysis and Cancer Susceptibility J. Jack Lee (University of Texas MD Anderson Cancer Center, USA) Clinical Trial for Novel Cancer Therapy in Precision Medicine Era Christophe Le Tourneau (Institut Curie, France) Frontier of Precision Medicine in Oncology: Progress of SHEVA Trial

Teresa K. Woodruff (Obstet and Gynecology, Northwestern University, USA) Recent Advancement on Fertility Preservation of Young Cancer Patients: Globalization of Oncofertility Consortium Hamish Wallace (Royal Hospital for Sick Children, The University of Edinburgh, UK) Evaluation of Ovarian Tissue Cryopreservation and Transplantation based on Edinburgh Selection Criteria Jonathan A. Ledermann (University College London, UK) Personalization in Gynecologic Cancer Therapeutics: Future Perspective Elise C. Kohn (National Cancer Institute, USA) Molecular Profiling and Ovarian Cancer Treatment; Where are we Now?

Helen MacKay (Princess Margaret Hospital, University of Toronto, Canada) Intratumoral Genetic Heterogeneity of Ovarian Cancer Noralane M. Lindor (Laboratory Medicine and Pathology, Mayo Clinic, USA) Genetic Counseling and Management for Hereditary Cancer Risk in USA David E. Cohn (Obstetrics and Gynecology, The Ohio State University, USA) Prevention of Breast and Ovarian Cancer in HBOC Family Members Fortunato Ciardiello (President Elect of ESMO, Napoli, Italy) Toward Personalized Medicine in Oncology: Current and Future Perspective

Julie M. Vose (President Elect of ASCO, Nebraska Medical Center, USA) My Life and Academic Career Peter Naredi (President Elect of ECCO, University of Gothenburg, Sweden) Personalization of Surgery and Management for Hepatocellular Carcinoma David I. Quinn(USC Norris Comprehensive Cancer Center, Keck School of Medicine of USC) Precision Medicine in Multidisciplinary Therapy for Renal Cancer Arno J. Mundt (UC San Diego Moores Cancer Center, USA) Chemoradiotherapy for Locally Advanced Cervical Cancer: Where are we now?

Charles M. Rudin(Memorial Sloan Kettering Center, USA) Precision Medicine for Lung Cancer Therapy: Future Perspective Antonio Palumbo(Department of Oncology, University of Torino, Italy) Personalized Treatment for Multiple Myeloma Carol R. Bradford (Otolaryngology, Head and Neck Surgery, University of Michigan, USA) New Era on Surgery, Chemotherapy and Radiotherapy for Head and Neck Cancer Johann S. de Bono (Drug Development Unit / Prostate Cancer Team, Institute of Cancer Research, Royal Marsden Hospital, UK) Recent Advancement of Personalized Therapy for Prostate Cancer

James L. Abbruzzese(Medical Oncology, Duke Cancer Institute, USA) Recent Global Advances in Pancreas Cancer Therapeutics Michael J. Birrer(Massachusetts General Hospital, Harvard Medical School, USA) Future Direction of Ovarian Cancer Research and Clinical Trials David Chibula (Obstetrics and Gynecology, Charles University, Czech Republic) Personalization of Surgery for Endometrial Cancer John M. Maris (The Children's Hospital of Philadelphia, USA) Precision Medicine for Childhood Cancer Treatment

Julio Garcia-Aguila (Colorectal Surgery, Memorial Sloan Kettering Cancer Center, USA) Personalization of Surgery, Chemotherapy and Radiotherapy for Colorectal Cancer